Measles vaccine, mumps vaccine, rubella vaccine, Live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), chicken pox vaccine, oral polio vaccine (Sabin), rotavirus vaccine, and yellow fever vaccine.
Since then, thimerosal has a long record of safe and effective use preventing bacterial and fungal contamination of vaccines, with no ill effects established other than minor local reactions at the site of injection. As a vaccine preservative, thimerosal is used in concentrations of 0.003% to 0.01%. A vaccine containing 0.01% thimerosal as a preservative contains 50 micrograms of thimerosal per 0.5 ml dose or approximately 25 micrograms of mercury per 0.5 mL dose. Since 2001, all vaccines recommended for children 6 years of age and younger have contained either no thimerosal or only trace amounts, with the exception of inactivated influenza vaccines, which are marketed in both the preservative-free and thimerosal-preservative-containing formulations. What vaccines you need depends on your age, health, and what vaccines you have already had. For most adults who received all their recommended vaccines as children, only a yearly flu vaccine and a tetanus booster every 10 years are needed. However, you should talk to your doctor about what’s best for you.  Vaccines Administered at Well-child Visits. When vaccines are provided as part of a well-child encounter, the ICD-9 guidelines instruct that code V20.2 (routine infant or child health check) includes immunizations appropriate to the patient's age.  Appendix B of the CDC publication Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) contains a list of vaccines used outside the U.S. You'll find Appendix B at www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/foreign-products-tables.pdf. Instructions on the use of VISs and many additional items are available on the CDC website at www.cdc.gov/vaccines/hcp/vis/index.html or from your state immunization program. You can also visit IAC's website at www.immunize.org/vis for links to many important documents about the use of VISs. With the addition of influenza vaccine to the recommended vaccines, an infant could receive a thimerosal-containing influenza vaccine at 6 and 7 months of age. This would result in a maximum exposure or 28 micrograms via routine childhood vaccinations. Since 2001, all vaccines recommended for children 6 years of age and younger have contained either no thimerosal or only trace amounts, with the exception of inactivated influenza vaccines, which are marketed in both the preservative-free and thimerosal-preservative-containing formulations. Furthermore, all new vaccines licensed since 1999 are free of thimerosal as a preservative. Inactivated influenza vaccine was added to the routinely recommended vaccines for children 6 to 23 months of age in 2004. Since 2001, all vaccines recommended for children 6 years of age and younger have contained either no thimerosal or only trace amounts, with the exception of inactivated influenza vaccines, which are marketed in both the preservative-free and thimerosal-preservative-containing formulations. A attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or live). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by killing the virus (inactivated vaccine). Examples of live (example attenuated) vaccines include: 1  Viral: measles vaccine, mumps vaccine, rubella vaccine, Live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), chicken pox vaccine, oral polio vaccine (Sabin), rotavirus vaccine, and yellow fever vaccine. A subunit vaccine presents an antigen to the immune system without introducing viral particles, whole or otherwise. One method of production involves isolation of a specific protein from a virus and administering this by itself. An enzyme composed of both regulatory and catalytic subunits when assembled is often referred to as a holoenzyme. For example, class I phosphoinositide 3-kinase is composed of a p110 catalytic subunit and a p85 regulatory subunit. One subunit is made of one polypeptide chain. A polypeptide chain has one gene coding for it – meaning that a protein must have one gene for each unique subunit. A subunit is often named with a Greek or Roman letter, and the numbers of this type of subunit in a protein is indicated by a subscript. For example, ATP synthase has a type of subunit called α. Three of these are present in the ATP synthase molecule, and is therefore designated α 3 The U.S. Food and Drug Administration (FDA) has approved the use of one dose of vaccine against 2009 H1N1 influenza virus for persons 10 years of age and older. For children who are 6 months through 9 years of age, two doses of the vaccine are recommended. These two doses should be separated by 4 weeks. If you have had 2009 H1N1 flu, as confirmed by an RT-PCR test, you should have some immunity against 2009 H1N1 flu and can choose not to get the 2009 H1N1 vaccine. However, vaccination of a person with some existing immunity to the 2009 H1N1 virus will not be harmful.
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430 http://wwwnc.cdc.gov/travel/diseases/routine http://www.aafp.org/practice-management/payment/coding/admin.html http://www.immunize.org/askexperts/documenting-vaccination.asp http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430 http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/UCM070430 https://en.wikipedia.org/wiki/Attenuated_vaccine https://en.wikipedia.org/wiki/Protein_subunit http://www.cdc.gov/h1n1flu/vaccination/public/vaccination_qa_pub.htm
what are some example of a disses submit by a vaccine